Does intravenous cefuroxime improve the efficacy of ciprofloxacin for preventing infectious complications after transrectal prostate biopsy? A prospective comparative study
Khalid Al Rumaihi1, Ahmad A Majzoub1, Nagy Younes1
1Department of Urology, Hamad Medical Corporation, Doha, Qatar.
Objectives:
To compare the frequency of infection after transrectal ultrasonography (TRUS)-guided biopsy of the prostate (TRUSBP) using prophylactic ciprofloxacin with or without adding cefuroxime.
Patients And Methods:
Between June 2008 and October 2009, 205 consecutive patients had TRUSBP with the use of oral 500 mg ciprofloxacin twice per day, 2 days before and 3 days after the biopsy (defined as group A). Starting from November 2009 and onwards, 250 consecutive patients had TRUSBP using the same previous protocol of antibiotic prophylaxis but with the addition of intravenous 1.5 g cefuroxime given 30 min before the procedure (defined as group B). The incidence of sepsis after TRUSBP, together with the results of urine and blood cultures and antibiotic sensitivity, were compared between the groups.
Results:
Fever after TRUSBP was recorded in 18 of 205 patients in group A (8.8%) and in nine of 250 in group B (3.6%); the difference was significant (P = 0.018). Urine culture was positive in 14 and five of patients in groups A and B, respectively, with extended-spectrum β-lactamase-producing (ESBL) Escherichia coli as the most common organism. The blood culture was positive in seven and three patients in groups A and B, respectively, with ESBL E. coli as the most common organism. All patients who had sepsis after TRUSBP sepsis were treated successfully.
Conclusion:
Adding a single intravenous injection with 1.5 g of cefuroxime to oral ciprofloxacin significantly reduced the frequency of infectious complications after TRUSBP.
Insights
Adding cefuroxime to ciprofloxacin prophylaxis significantly reduces infection rates after transrectal ultrasonography-guided prostate biopsy (TRUSBP). This combination therapy is more effective in preventing infectious complications and sepsis following the procedure.
Area of Science:
- Urology
- Infectious Diseases
- Pharmacology
Background:
- Transrectal ultrasonography-guided prostate biopsy (TRUSBP) is associated with infectious complications.
- Antibiotic prophylaxis is standard, but optimal regimens require further investigation.
Purpose of the Study:
- To compare the incidence of infection after TRUSBP using prophylactic ciprofloxacin alone versus ciprofloxacin plus cefuroxime.
Main Methods:
- A prospective study comparing two groups of patients undergoing TRUSBP.
- Group A received oral ciprofloxacin; Group B received oral ciprofloxacin plus intravenous cefuroxime prior to biopsy.
- Infection rates, sepsis incidence, and culture results were analyzed.
Main Results:
- Infectious complications (fever) were significantly lower in the cefuroxime group (3.6%) compared to the ciprofloxacin-only group (8.8%).
- Positive urine and blood cultures, primarily with extended-spectrum β-lactamase-producing Escherichia coli, were also reduced with the addition of cefuroxime.
- All cases of sepsis were successfully treated.
Conclusions:
- Adding intravenous cefuroxime to oral ciprofloxacin significantly decreases infectious complications after TRUSBP.
- This enhanced prophylactic regimen improves patient safety during prostate biopsy procedures.
Related Concept Videos
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
01:22Imaging Studies V: Intravenous Urography and Retrograde Pyelography
01:26Urine Studies II: Urine Culture and Sensitivity Test